HEARTBEAM INC
BEATNASDAQTrading Snapshot
- Day Range
- $0.37 β $0.37
- 52-Week Range
- $0.36 β $4.00
- Volume
- $2.06B
- Avg Volume
- $2.75B
- Shares Outstanding
- 55.5M
- Next Earnings
- Oct 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $541,395
- P/E Ratio
- -0.7
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-0.38
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +26.0%
Why Investors Own BEAT
- βHigh-growth profile β revenue up +58.0% YoY with expanding US Equity exposure.
- βHealthy economics β 79% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HEARTBEAM INC
BEATAbout HEARTBEAM INC
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
HEARTBEAM INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift BEAT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
HEARTBEAM INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.